Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



AstraZeneca Faces Investigation by Chinese Regulator, Shares Decline

December 21, 2024
AstraZeneca PLC (AZN) shares have experienced a significant drop after reports emerged of a probe by the People's Republic of China (PRC) regarding alleged fraud and corruption. The Chinese regulator is conducting an investigation into AstraZeneca's business operations and practices within the country. This news has raised concerns among investors, leading to a decline in the company's stock value. AstraZeneca has yet to release an official statement regarding the probe. Investors are advised to seek professional guidance, such as Stocks Prognosis, for a forecast on the future movement of AstraZeneca's shares.
If you want to leave a comment, then you need Login or Register





Other data for AZN

Related data

AZNAugust 25, 2025AstraZeneca's Breakthrough Study on Advanced Biliary Tract Cancer  ~1 min.

AstraZeneca PLC has recently announced groundbreaking results from their new study on advanced biliary tract cancer, showing promising potential for a new treatment option in cancer care....


AZNAugust 22, 2025ASTRAZENECA PLC Hits Price Target Forecast with 20.55% Profit  ~1 min.

On January 23, 2025, QuantWave issued a long signal for ASTRAZENECA PLC with a price of 67.17 $. The forecast proved to be accurate as the stock reached the target price of 80....


AZNAugust 22, 2025ASTRAZENECA PLC Stock Hits QuantWave's Price Target Forecast with 14.63% Profit  ~1 min.

ASTRAZENECA PLC stock has successfully reached the price target forecast provided by QuantWave, resulting in a profitable outcome for investors....


AZNAugust 20, 2025ASTRAZENECA PLC Stock Hits Price Target, Yielding 14.58% Profit - QuantWave Prediction Success  ~2 min.

On June 18, 2025, QuantWave issued a long forecast signal for ASTRAZENECA PLC when the stock was trading at $70.27....


AZNAugust 20, 2025ASTRAZENECA PLC Hits Price Target Forecast with 16.44% Profit: A Win for QuantWave  ~1 min.

ASTRAZENECA PLC, one of the leading pharmaceutical companies, has seen its stock price hit the forecasted target with a substantial 16....


AZNAugust 20, 2025ASTRAZENECA PLC Stock Hits Price Target, Generating 13.99% Profit for QuantWave Users  ~2 min.

On July 2, 2025, QuantWave, an automated forecasting platform, issued a price target forecast for ASTRAZENECA PLC with a long signal at a price of 70.64 $....


AZNAugust 20, 2025ASTRAZENECA PLC Hits Price Target Forecast with a 15.91% Profit  ~1 min.

QuantWave's forecast signal for ASTRAZENECA PLC on June 20, 2025, proved to be accurate as the stock reached the predicted target on August 20, 2025. The price at the time of the signal was 69....


AZNAugust 20, 2025ASTRAZENECA PLC Hits QuantWave Forecast Target with 15.71% Profit  ~1 min.

On June 26, 2025, QuantWave's automated forecasting platform issued a long signal for ASTRAZENECA PLC with a price target of $80.52. The stock was trading at $69....


AZNAugust 20, 2025ASTRAZENECA PLC Stock Hits Forecast Price Target with Profit of 13.46%: QuantWave Analysis  ~2 min.

ASTRAZENECA PLC's stock recently achieved the price target forecasted by QuantWave with a profit of 13.46%....


AZNAugust 20, 2025ASTRAZENECA PLC Hits Price Target Forecast with 16.75% Profit  ~1 min.

On July 3, 2025, QuantWave's forecast signal indicated a long position for ASTRAZENECA PLC when the stock was priced at 68.97 $. Today, on August 20, 2025, the price of ASTRAZENECA PLC reached 80....


AZNJanuary 23, 2025Robbins LLP Encourages AZN Shareholders with Large Losses to Seek Counsel in the AstraZeneca PLC Class Action  ~2 min.

AstraZeneca PLC, a globally renowned pharmaceutical company, is facing a potential setback as Robbins LLP, a leading shareholder rights litigation firm, encourages AZN shareholders with significant losses to seek legal counsel in the AstraZeneca PLC class action. The class action alleges that AstraZeneca PLC made false and misleading statements regarding the efficacy and safety of its COVID-19 vac...


AZNJanuary 25, 2025AstraZeneca PLC Faces Class Action Lawsuit for Investor Recovery  ~2 min.

Robbins LLP, a leading investor rights law firm, is encouraging shareholders of AstraZeneca PLC (AZN) who have suffered significant financial losses to seek legal counsel in the ongoing class action lawsuit against the company. The lawsuit, filed by Levi Korsinsky, aims to recover damages for investors who suffered losses due to alleged misleading statements and omissions made by AstraZeneca regar...


AZNJanuary 9, 2025The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline in AstraZeneca PLC Lawsuit  ~1 min.

AstraZeneca PLC (NASDAQ: AZN) recently faced a class action lawsuit, and The Gross Law Firm is reminding shareholders about an upcoming lead plaintiff deadline of February 21, 2025....


AZNFebruary 9, 2025Deadline Alert: AstraZeneca PLC AZN Investors Who Lost Money Urged To Contact Glancy Prongay Murray LLP About Securities Fraud Lawsuit  ~1 min.

AstraZeneca Plc (AZN) investors who have suffered financial losses are urged to contact Glancy Prongay & Murray LLP regarding a securities fraud lawsuit....


AZNJanuary 26, 2025Class Action Filed Against AstraZeneca PLC AZN Seeking Recovery for Investors  ~1 min.

Robbins LLP Encourages AZN Shareholders with Large Losses to Seek Counsel in the AstraZeneca PLC Class Action....